The AeroEclipse® II  Breath Actuated Nebulizer (BAN) creates aerosol in response to the patient's inspiratory flow.  This patient on-demand therapy means less medication waste, higher drug delivery efficiency and safer clinician working environments.

Combining the benefits of breath actuation and a superior aerosol particle size, the AeroEclipse® II BAN delivers the industry’s most effective respirable dose. Supported by clinical evidence, the AeroEclipse® II BAN provides approved dosing protocols throughout the hospital and for all patient populations. 

• Breath actuated technology
• Consistent respirable dose
• Virtually no drug is lost to the environment
• Protection from second-hand aerosols
• Minimizes medication waste 
• Efficient treatment times
• Biofeedback button confirms actuation and inhalation 
• Reduced Length of Stay and Admission Rates through the ER1
• Not Made or Manufactured with BPA, Natural Rubber Latex, Phthalates, Lead, or PVC 
• Designed and manufactured in North America
• 15 LPM

The AeroEclipse® II  Breath Actuated Nebulizer (BAN) creates aerosol in response to the patient's inspiratory flow.  This patient on-demand therapy means less medication waste, higher drug delivery efficiency and safer clinician working environments.

Combining the benefits of breath actuation and a superior aerosol particle size, the AeroEclipse® II BAN delivers the industry’s most effective respirable dose. Supported by clinical evidence, the AeroEclipse® II BAN provides approved dosing protocols throughout the hospital and for all patient populations. 

• Breath actuated technology
• Consistent respirable dose
• Virtually no drug is lost to the environment
• Protection from second-hand aerosols
• Minimizes medication waste 
• Efficient treatment times
• Biofeedback button confirms actuation and inhalation 
• Reduced Length of Stay and Admission Rates through the ER1
• Not Made or Manufactured with BPA, Natural Rubber Latex, Phthalates, Lead, or PVC 
• Designed and manufactured in North America